ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
GSK to make chickenpox vaccine in Russia in deal with Nanolek fiercepharma
September 26, 2019The deal comes as GSK continues to see good growth in vaccines, which tallied ￡1.6 billion ($1.9 million) in Q2, up 26%. That was driven by strong demand for Shingrix in the U.S. after the shingles vaccine won a U.S. CDC recommendation in 2018.?
Pharma Sources Insight January 2025
